human Mesenchymal Stem Cell (MSC) infusion therapy
Protocol LMC-101
Phase 1 mab active
Quick answer
human Mesenchymal Stem Cell (MSC) infusion therapy for Aging Well is a Phase 1 program (mab) at CytoMed Therapeutics Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CytoMed Therapeutics Ltd
- Indication
- Aging Well
- Phase
- Phase 1
- Modality
- mab
- Status
- active